Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Primary Care
  • FREE for Members
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
  • Contact hours
$10.00
0.5 contact hour of which 0.5 contain pharmacology content and 0.5 controlled substances.This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Urine drug screening (UDS) is a laboratory test frequently used to screen for drugs of abuse, monitor for medication compliance, evaluate for suspected drug intoxication or overdose, and in office-based pain contracts (Kale, 2019; Standridge, Adams, & Zotos, 2010). In children and adolescents,UDS may be used to prevent substance use, evaluate for suspected drug use or intoxication, or as part of substance abuse treatment (Levy & Siqueira, 2014). When using UDS as a tool to make clinical decisions about high-risk medications, it is important to understand the differences between UDS testing modalities, common causes of falsepositive or false-negative results, and the detection window of specific medications. There are two commonly used types of UDS available: immunoassay and gas chromatography/ mass spectrometry (GC-MS; Kale, 2019).
  • FREE for Members
  • Pharmacology CE
  • Contact hours
$10.00
0.75 NAPNAP Contact Hour of which contains 0.75 pharmacology content.. This continuing education activity is offered free to National Association of Pediatric Nurse Practitioners (NAPNAP) Members. For non- members, this continuing education activity rate is $10. Magnesium is the second most abundant intracellular cation in the body, and the fourth most abundant cation. Sixty percent of total body magnesium is stored in bone, 20% is located in skeletal muscle and the remaining 20% is distributed in various organ tissues, including the kidney, liver, and heart (Grober, Schmidt, & Kisters, 2015). Approximately 0.3% of magnesium is found in the serum (Grober et al., 2015). Therefore, determination of the serum magnesium concentration remains the best readily available test for magnesium deficiency, although it provides only an estimate of total body magnesium stores.This review article provides an overview of key disease states in pediatric patients where magnesium is part of the treatment. The treatment of hypomagnesemia and hypermagnesemia will be described, with review of dosing and timing of magnesium administration. J Pediatr Health Care. (2021) 35, 564-571.
  • FREE for Members
  • Pharmacology CE
  • Contact hours
$10.00
1.0 contact hour of which 1.25 contain pharmacology content. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Clostridioides difficile infection (CDI) is a major public health concern for pediatric and adult patients. The management of pediatric CDI poses a challenge to healthcare providers due to lack of strong randomized controlled trials to guide pharmacological management. Additionally, recent updates to CDI guidelines recommend oral vancomycin over metronidazole for the management of CDI in adults, leaving questions regarding how to best manage pediatric patients. This continuing education pharmacotherapy review describes available evidence for the safety and efficacy of medications used in the treatment and management of pediatric CDI and aims to clarify discrepancies between pediatric and adult recommendations.
  • Primary Care
  • FREE for Members
  • Pharmacology CE
  • Contact hours
$10.00
1.0 NAPNAP Contact Hour of which 0.25 contain Pharmacology content. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Psoriasis, which affects up to 2% of children may be associated with significant comorbidity, including obesity, diabetes, cardiovascular disease, depression, and reduced quality of life. Screening and decision-making require a multidisciplinary approach with the management of potential comorbidities championed by primary care providers and supported by respective specialists and subspecialists. Research into the comorbidities and systemic manifestations has generated significant data culminating in several proposals for a consensus guideline for both pediatric and nonpediatric populations. Our aim is to provide a summary targeted to the pediatric primary care provider from the best available evidence when caring for children with psoriasis. J Pediatr Health Care. (2021) 35, 337−350
  • Primary Care
  • Acute Care
  • FREE for Members
  • Infectious Disease
  • Immunization
  • Pharmacology CE
  • Contact hours
$12.50
1.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $12.50. While sharing the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines.